Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01411488 · ClinicalTrials.gov registry record · NA
Comparative Study Between Two Fecal Management Systems
A NA study of Anal Erosion, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT01411488 is a NA study of Anal Erosion that has completed, run by The Cleveland Clinic. The registered enrollment target is 90 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01411488, a NA study of Anal Erosion, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to determine the prevalence of anal erosions within a 14 day period among adult ICU patients at Cleveland Clinic Main Campus who receive one of two fecal management systems (FMS). Null Hypothesis: There is no difference in the rates of anal erosion between the twp fecal management systems in a 14 day period. Alternative Hypothesis: One fecal management system is no worse than the second fecal management system in the development of anal erosion.
Conditions Studied
Interventions
- DEVICE Fecal management system
Study Locations (1)
Ohio
- Cleveland Clinic Main Campus - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2011-01 |
| Est. Completion | 2012-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01411488
The ClinicalTrials.gov registry entry for NCT01411488 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anal Erosion appearing as the primary indexed condition, and to 1 intervention - of which Fecal management system is the first listed.
NCT01411488 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT01411488 about?
NCT01411488 is a clinical study titled "Comparative Study Between Two Fecal Management Systems". The purpose of the study is to determine the prevalence of anal erosions within a 14 day period among adult ICU patients at Cleveland Clinic Main Campus who receive one of two fecal management systems (FMS). Null Hypothesis: There is no difference in the rates of anal erosion between the twp fecal ...
What is the current status of trial NCT01411488?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2011-01. Estimated completion is 2012-05.
What conditions does trial NCT01411488 study?
This clinical trial studies the following conditions: Anal Erosion.
What interventions are being tested in trial NCT01411488?
The interventions under investigation include: Fecal management system (DEVICE).
Who is sponsoring clinical trial NCT01411488?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01411488 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.